Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium
Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …
Sex‐based differences in severity and mortality in COVID‐19
The current coronavirus disease (COVID‐19) pandemic caused by novel severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has a male bias in severity and …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has a male bias in severity and …
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
E Pretorius, M Vlok, C Venter, JA Bezuidenhout… - Cardiovascular …, 2021 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced
infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by acute …
infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by acute …
SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities
MS Alam, DM Czajkowsky - Cytokine & Growth Factor Reviews, 2022 - Elsevier
The current coronavirus disease 2019 (COVID-19) pandemic has presented unprecedented
challenges to global health. Although the majority of COVID-19 patients exhibit mild-to-no …
challenges to global health. Although the majority of COVID-19 patients exhibit mild-to-no …
ICU admission levels of endothelial biomarkers as predictors of mortality in critically ill COVID-19 patients
Endotheliopathy is suggested to be an important feature of COVID-19 in hospitalized
patients. To determine whether endotheliopathy is involved in COVID-19-associated …
patients. To determine whether endotheliopathy is involved in COVID-19-associated …
Increased VWF and decreased ADAMTS-13 in COVID-19: creating a milieu for (micro) thrombosis
von Willebrand factor (VWF) is a large adhesive multimeric protein involved in hemostasis.
The larger the size (or number of VWF multimers), the greater the functionality of the protein …
The larger the size (or number of VWF multimers), the greater the functionality of the protein …
[HTML][HTML] NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel
N Krinsky, S Sizikov, S Nissim, A Dror, A Sas… - Journal of Thrombosis …, 2023 - Elsevier
Background COVID-19 severity and its late complications continue to be poorly understood.
Neutrophil extracellular traps (NETs) form in acute COVID-19, likely contributing to morbidity …
Neutrophil extracellular traps (NETs) form in acute COVID-19, likely contributing to morbidity …
Coronavirus disease 2019–associated coagulopathy
Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
Hematological changes associated with COVID‐19 infection
EAKD Al‐Saadi, MA Abdulnabi - Journal of clinical laboratory …, 2022 - Wiley Online Library
Background The unresolved COVID‐19 pandemic considerably impacts the health services
in Iraq and worldwide. Consecutive waves of mutated virus increased virus spread and …
in Iraq and worldwide. Consecutive waves of mutated virus increased virus spread and …
COVID-19 and thrombosis: The role of hemodynamics
Abstract Severe coronavirus disease 2019 (COVID-19) is characterized by an increased risk
of thromboembolic events, a leading cause for adverse outcomes in patients afflicted by the …
of thromboembolic events, a leading cause for adverse outcomes in patients afflicted by the …